Back to News
Market Impact: 0.2
Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm
Source: newsfilecorp.com
Legal & Litigation
Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities-law violations by Cellebrite DI Ltd. (NASDAQ: CLBT). The notice provides no alleged damages, financial figures, specific claims, or company response, but introduces legal and reputational risk for the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CLBT-0.80
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- David Ellison goes minimalist with his new name for his Paramount-Skydance-Warner-Bros-Discovery empire
- Paramount-WBD Will Now Be Called Skydance, David Ellison Reveals
- Paramount and Warner Bros. Discovery to Merge Into Skydance (SKYD). Will Skydance Achieve David Ellison’s "Quality Storytelling" Vision?
- Lyft agrees to pay $272.5 million to settle worker classification lawsuit
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AlphaSense Pricing: What Public Contract Data Shows in 2026
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market